S GORDONII AS A VECTOR FOR P GINGIVALIS FIMBRILLIN
S GORDONII 作为 P Gingivalis Fimbrillin 的载体
基本信息
- 批准号:2372351
- 负责人:
- 金额:$ 16.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-09-20 至 2000-09-19
- 项目状态:已结题
- 来源:
- 关键词:Bacteroides gingivalis Streptococcus antibiotics antigen antibody reaction bacterial proteins bactericidal immunity biotechnology drug design /synthesis /production genetic strain implant laboratory rat microorganism interaction microorganism mass culture oral bacteria periodontium disorder pilus recombinant DNA transfection virulence
项目摘要
DESCRIPTION (Adapted from the investigator's Abstract): The broad,
long-term goal of this project is to develop a system for continuous
production of biologically active factors which block mucosal infections.
The applicant proposes the development of genetically engineered strains of
the commensal organism, Streptococcus gordonii, which expresses
Porphyromonas gingivalis fimbrillin polypeptides capable of blocking
adherence, and of inducing a protective immune response. The specific aims
are: (1) to further characterize the expression system recently developed
in our laboratory for P. gingivalis fimbrillin on the surface of S.
gordonii; (2) to optimize a secretion system in S. gordonii for the
production of P. gingivalis fimbrillin; and (3) to test these genetically
engineered strains of S. gordonii in the rat model of periodontal disease
for reduction of colonization with P. gingivalis and for protection against
destructive periodontitis. S. gordonii was selected since it is a
non-pathogenic commensal organism, universally found in the human oral
cavity, and strains have been genetically engineered to express foreign
antigens. P. gingivalis is an important pathogen in a well-established
model of mucosal infection, periodontal disease, and its fimbrillin subunit
was selected since it has been cloned and sequenced. Furthermore, P.
gingivalis fimbrillin domains involved in adherence and in the immune
response have been determined. Recombinant S. gordonii strains have been
generated that express biologically active domains of fimbrillin and have
shown that they are able to generate fimbrillin-specific immune response in
rats following oral colonization as well as after parenteral immunization.
Rats infected with P. gingivalis were selected as a model of mucosal
infection in which to study the early steps in the disease process, namely
adherence and colonization, since it is well characterized and provides a
useful model to assess in vivo efficacy of a genetically engineered
commensal organism producing factors which interfere with virulence.
Therefore, studies are proposed to generate recombinant strains of S.
gordonii able to either secrete or surface express important fimbrillin
peptides, and capable of modulating P. gingivalis infection in a rat model
of periodontal disease. Such genetically engineered strains of S. gordonii
expressing fimbrillin peptides may be used as a vaccine against P.
gingivalis infection, and as a model to study this novel approach to
vaccines for other mucosal infections. The model can also be used for
evaluating the utility of continuously expressed biologically active
molecules by commensal organisms, directed to block colonization and other
key early stages in the pathogenesis of mucosal infections.
描述(改编自研究者摘要):广泛,
该项目的长期目标是开发一个系统,
产生阻断粘膜感染的生物活性因子。
本申请人提出了开发基因工程菌株,
这种细菌,戈登链球菌,
能够阻断牙龈卟啉单胞菌菌毛蛋白的多肽
粘附和诱导保护性免疫应答。 具体目标
主要有:(1)进一步表征最近开发的表达系统
在我们的实验室中,牙龈卟啉单胞菌菌毛蛋白在S.
gordonii;(2)优化S. gordonii为
牙龈卟啉单胞菌菌毛蛋白的产生;和(3)测试这些基因
S.牙周病大鼠模型的研究
用于减少牙龈卟啉单胞菌的定殖和用于防止
破坏性牙周炎 S.选择戈登II是因为它是一个
非致病性口腔微生物,普遍存在于人类口腔
腔,菌株已被基因工程改造,以表达外源
抗原 牙龈卟啉单胞菌是一种重要的病原体,
粘膜感染、牙周病及其菌毛蛋白亚单位的模型
因为它已经被克隆和测序。 此外,P.
牙龈菌毛蛋白结构域参与粘附和免疫
答案已经确定。 重组变异链球菌戈登氏菌株已经被
产生表达菌毛蛋白的生物活性结构域并且具有
表明它们能够在体内产生菌毛蛋白特异性免疫应答,
口服定植后以及胃肠外免疫后的大鼠。
选择牙龈卟啉单胞菌感染的大鼠作为粘膜炎模型,
研究疾病过程的早期步骤,即
坚持和殖民化,因为它是很好的特点,并提供了一个
用于评估遗传工程改造的药物组合物的体内功效的有用模型
干扰毒力的微生物产生因子。
因此,建议进行研究以产生S.
戈登氏菌能够分泌或表面表达重要的菌毛蛋白
肽,并且能够在大鼠模型中调节牙龈卟啉单胞菌感染
牙周病的症状 这些基因工程菌株的S。戈登链球菌
表达菌毛蛋白肽的疫苗可用作抗P.
牙龈感染,并作为一个模型来研究这种新的方法,
其他粘膜感染的疫苗。 该模型还可用于
评价连续表达的生物活性物质的效用
分子的生物体,直接阻止殖民和其他
粘膜感染发病机制的关键早期阶段。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ashu Sharma其他文献
Ashu Sharma的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ashu Sharma', 18)}}的其他基金
Bacterial sialometabolic activity impacts periodontal immunity and microbiota
细菌唾液酸代谢活动影响牙周免疫和微生物群
- 批准号:
10520050 - 财政年份:2020
- 资助金额:
$ 16.85万 - 项目类别:
Bacterial sialometabolic activity impacts periodontal immunity and microbiota
细菌唾液酸代谢活动影响牙周免疫和微生物群
- 批准号:
10310503 - 财政年份:2020
- 资助金额:
$ 16.85万 - 项目类别:
Novel Mechanisms of Peptidoglycan Synthesis in Tannerella forsythia
连翘坦纳菌肽聚糖合成的新机制
- 批准号:
8700049 - 财政年份:2014
- 资助金额:
$ 16.85万 - 项目类别:
Novel Mechanisms of Peptidoglycan Synthesis in Tannerella forsythia
连翘坦纳菌肽聚糖合成的新机制
- 批准号:
8845539 - 财政年份:2014
- 资助金额:
$ 16.85万 - 项目类别:
B.forsythus BsPA protein: role in virulence
B.forsythus BsPA 蛋白:在毒力中的作用
- 批准号:
6824886 - 财政年份:2003
- 资助金额:
$ 16.85万 - 项目类别:
Tannerella forsythia intercations with host cells and other bacteria
连翘坦纳菌与宿主细胞和其他细菌的相互作用
- 批准号:
8230727 - 财政年份:2003
- 资助金额:
$ 16.85万 - 项目类别:
T. forsythia TLR2 ligands and surface glycans coordinate periodontal inflammation
连翘 TLR2 配体和表面聚糖协调牙周炎症
- 批准号:
8759749 - 财政年份:2003
- 资助金额:
$ 16.85万 - 项目类别:
Tannerella forsythia intercations with host cells and other bacteria
连翘坦纳菌与宿主细胞和其他细菌的相互作用
- 批准号:
7461124 - 财政年份:2003
- 资助金额:
$ 16.85万 - 项目类别:
T. forsythia TLR2 ligands and surface glycans coordinate periodontal inflammation
连翘 TLR2 配体和表面聚糖协调牙周炎症
- 批准号:
9296119 - 财政年份:2003
- 资助金额:
$ 16.85万 - 项目类别:
Tannerella forsythia intercations with host cells and other bacteria
连翘坦纳菌与宿主细胞和其他细菌的相互作用
- 批准号:
7775121 - 财政年份:2003
- 资助金额:
$ 16.85万 - 项目类别:
相似国自然基金
Streptococcus_salivarius 菌经肠肝轴定植肿瘤
微环境促进肝癌侵袭转移的分子机制研究
- 批准号:Z24H160023
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
耳鼻咽喉头颈痛内菌Streptococcus mitis扰乱CAF细胞GSH代谢促进头颈鳞癌演进的机制研究
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:青年科学基金项目
影响Streptococcus pyogenes CRISPR/Cas9脱靶的相关因素及其靶向特异性机制研究
- 批准号:31770069
- 批准年份:2017
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
Oral bacterium Streptococcus mutans promotes tumor metastasis via thrombosis formation
口腔细菌变形链球菌通过血栓形成促进肿瘤转移
- 批准号:
24K19985 - 财政年份:2024
- 资助金额:
$ 16.85万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Identifying the correlates of protection against Streptococcus pneumoniae respiratory tract infection using a human challenge model
使用人体挑战模型确定预防肺炎链球菌呼吸道感染的相关性
- 批准号:
MR/Z503721/1 - 财政年份:2024
- 资助金额:
$ 16.85万 - 项目类别:
Research Grant
The impact of thermally-regulated cell wall modifications on Streptococcus pneumoniae pathogenesis
热调节细胞壁修饰对肺炎链球菌发病机制的影响
- 批准号:
MR/X009130/1 - 财政年份:2023
- 资助金额:
$ 16.85万 - 项目类别:
Research Grant
An RNA vaccines systems approach to Group A streptococcus vaccine discovery
发现 A 组链球菌疫苗的 RNA 疫苗系统方法
- 批准号:
10577082 - 财政年份:2023
- 资助金额:
$ 16.85万 - 项目类别:
The impact of environmental conditions on the prevalence and aerosol transmission of Streptococcus pyogenes
环境条件对化脓性链球菌流行和气溶胶传播的影响
- 批准号:
2879696 - 财政年份:2023
- 资助金额:
$ 16.85万 - 项目类别:
Studentship
Pre-labour invasion of the human uterus by Streptococcus agalactiae
无乳链球菌在产前侵入人类子宫
- 批准号:
MR/W025620/1 - 财政年份:2023
- 资助金额:
$ 16.85万 - 项目类别:
Research Grant
Discovery of a pigment produced by Streptococcus pyogenes
发现化脓性链球菌产生的色素
- 批准号:
10680293 - 财政年份:2023
- 资助金额:
$ 16.85万 - 项目类别:
Cardiomyocyte self-defense against Streptococcus pneumoniae
心肌细胞对抗肺炎链球菌的自我防御
- 批准号:
10639102 - 财政年份:2023
- 资助金额:
$ 16.85万 - 项目类别:
Strep-CaDI: A fast, accurate, and sensitive point-of-care test for Group A Streptococcus
Strep-CaDI:快速、准确且灵敏的 A 组链球菌现场检测
- 批准号:
10699852 - 财政年份:2023
- 资助金额:
$ 16.85万 - 项目类别:
Bacterial CRISPR interference to define macrophage responses to group B Streptococcus proteins
细菌 CRISPR 干扰定义巨噬细胞对 B 族链球菌蛋白的反应
- 批准号:
10724607 - 财政年份:2023
- 资助金额:
$ 16.85万 - 项目类别:














{{item.name}}会员




